Clinic
Memorial Health Systems INC
Memorial Health Systems INC was paid $6.19M by Medicaid between Jan 2018 and Jul 2024, across 193 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 11% of everything it billed.
33Billing provider infoMEMORIAL HEALTH SYSTEMS INC
DAYTONA BEACH, FL 32117
DAYTONA BEACH, FL 32117
33aNPI1063426823assigned 07/28/2006
33bProvider typeCardiac Rehabilitation Clinic/Center
28Total paid$6.19M
24GClaims252,175
24DCodes billed193
24AFirst – last monthJan 2018 – Jul 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,789 | $390K | |
| 2019 | 113,403 | $2.81M | |
| 2020 | 92,428 | $2.38M | |
| 2021 | 18,122 | $576K | |
| 2022 | 249 | $22K | |
| 2023 | 167 | $15K | |
| 2024incomplete | 17 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 3,940 | 3,446 | $671K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 18,099 | 16,578 | $658K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 5.9% | 1,680 | 1,510 | $368K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5.3% | 2,714 | 2,434 | $331K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.0% | 12,294 | 10,967 | $308K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.3% | 3,151 | 2,750 | $268K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.9% | 3,564 | 3,379 | $242K |
| 87420 | 3.2% | 1,902 | 1,822 | $200K | |
| 80053 | Comprehensive metabolic panel | 3.2% | 10,961 | 9,331 | $199K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.2% | 1,898 | 1,735 | $199K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 5,207 | 4,496 | $165K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 8,134 | 4,727 | $163K |
181 more codes
| 83516 | 2.4% | 798 | $147K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 1,169 | $110K |
| 81001 | 1.7% | 9,148 | $106K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.7% | 3,228 | $105K |
| 81025 | 1.6% | 5,012 | $98K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 2,464 | $91K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 1,528 | $91K |
| 99285 | Emergency room visit (most serious) | 1.4% | 4,832 | $88K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 6,061 | $85K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 1,211 | $83K |
| 59025 | Fetal non-stress test | 1.3% | 1,284 | $80K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 3,831 | $74K |
| 86850 | 1.0% | 1,376 | $65K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,787 | $60K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,696 | $60K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,839 | $60K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,207 | $57K |
| 82947 | <1% | 2,622 | $51K | |
| 81003 | <1% | 3,140 | $47K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,265 | $43K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 305 | $36K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,355 | $36K |
| 73610 | <1% | 493 | $34K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 834 | $32K |
| 74018 | <1% | 851 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,123 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,916 | $28K |
| 86901 | <1% | 1,773 | $26K | |
| 87070 | <1% | 569 | $25K | |
| 73630 | <1% | 489 | $23K | |
| 84484 | <1% | 4,155 | $20K | |
| 84702 | <1% | 1,593 | $18K | |
| 73110 | <1% | 336 | $18K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,916 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,445 | $16K |
| 73130 | <1% | 246 | $16K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 919 | $16K |
| 73562 | <1% | 310 | $15K | |
| 96376 | <1% | 850 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 700 | $13K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 172 | $13K |
| 76801 | <1% | 891 | $12K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 135 | $12K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 428 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,357 | $11K |
| 85610 | <1% | 4,005 | $10K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,354 | $10K |
| 87507 | <1% | 227 | $10K | |
| G0378 | Hospital observation service, per hour | <1% | 2,516 | $9K |
| 85730 | <1% | 2,700 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 130 | $9K |
| 73030 | <1% | 311 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 129 | $8K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 333 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,403 | $8K |
| 76377 | <1% | 325 | $8K | |
| 73080 | <1% | 109 | $7K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 207 | $6K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,192 | $6K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 651 | $6K |
| 93017 | <1% | 137 | $6K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 745 | $6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 93 | $6K |
| 82951 | <1% | 216 | $6K | |
| 86900 | <1% | 1,776 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,320 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 201 | $5K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 26 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,334 | $5K |
| 93971 | <1% | 230 | $4K | |
| 73090 | <1% | 66 | $4K | |
| 83735 | <1% | 1,476 | $4K | |
| 97597 | <1% | 157 | $4K | |
| 86140 | <1% | 889 | $4K | |
| 01999 | <1% | 663 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,789 | $4K |
| 87040 | <1% | 2,632 | $4K | |
| 72100 | <1% | 165 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 219 | $3K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 485 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 137 | $3K |
| 85027 | <1% | 622 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 203 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 647 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 43 | $3K |
| 80061 | Lipid panel | <1% | 1,056 | $3K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 41 | $3K |
| 74019 | <1% | 81 | $2K | |
| 82565 | <1% | 293 | $2K | |
| 83605 | <1% | 1,752 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,001 | $2K |
| 82247 | <1% | 148 | $2K | |
| 80050 | General health panel | <1% | 102 | $2K |
| 83690 | <1% | 3,378 | $2K | |
| 87077 | <1% | 2,213 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,651 | $2K |
| 73564 | <1% | 26 | $2K | |
| 83880 | <1% | 995 | $2K | |
| 82274 | <1% | 76 | $2K | |
| 73140 | <1% | 26 | $2K | |
| 76775 | <1% | 42 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 349 | $2K |
| 87486 | <1% | 1,030 | $2K | |
| 84703 | <1% | 705 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 277 | $2K |
| 84439 | <1% | 658 | $2K | |
| 84112 | <1% | 15 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 368 | $1K |
| 87186 | <1% | 1,778 | $1K | |
| 80076 | <1% | 184 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 127 | $986.99 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 25 | $970.54 |
| 87210 | <1% | 683 | $927.76 | |
| 71250 | <1% | 47 | $904.52 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $903.70 |
| 97161 | <1% | 18 | $879.68 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 684 | $872.85 |
| 87806 | <1% | 555 | $846.84 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 23 | $737.09 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,904 | $690.60 |
| 73502 | <1% | 14 | $644.02 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 437 | $595.99 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 757 | $527.31 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 389 | $507.10 |
| 12001 | <1% | 14 | $491.79 | |
| 86317 | <1% | 272 | $472.83 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 366 | $470.94 |
| 80074 | <1% | 198 | $468.38 | |
| 87581 | <1% | 257 | $465.89 | |
| 85018 | <1% | 324 | $409.79 | |
| 82728 | <1% | 50 | $404.31 | |
| 82570 | <1% | 112 | $379.50 | |
| 72110 | <1% | 13 | $365.82 | |
| 85379 | <1% | 503 | $357.20 | |
| 82550 | <1% | 158 | $339.28 | |
| 82105 | <1% | 32 | $337.72 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 26 | $326.07 |
| 0002A | <1% | 14 | $287.88 | |
| 82248 | <1% | 199 | $259.94 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 239 | $233.59 |
| 82805 | <1% | 43 | $229.63 | |
| 86780 | <1% | 124 | $226.09 | |
| 90715 | <1% | 75 | $198.08 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 28 | $190.08 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 167 | $159.76 |
| 99152 | <1% | 85 | $153.55 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 160 | $152.53 |
| 93970 | <1% | 14 | $141.32 | |
| 86787 | <1% | 187 | $139.48 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 30 | $124.80 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 994 | $108.38 |
| 0011A | <1% | 31 | $101.64 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 271 | $89.24 |
| 0001A | <1% | 21 | $84.70 | |
| 85014 | <1% | 466 | $83.91 | |
| 85652 | <1% | 192 | $80.21 | |
| 84145 | <1% | 84 | $72.86 | |
| 87340 | <1% | 448 | $67.61 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 17 | $41.96 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 138 | $34.58 |
| J2704 | Injection, propofol, 10 mg | <1% | 40 | $27.30 |
| 84156 | <1% | 91 | $12.46 | |
| 82330 | <1% | 15 | $6.62 | |
| 82607 | <1% | 20 | $5.07 | |
| 84466 | <1% | 53 | $3.92 | |
| 83540 | <1% | 55 | $3.36 | |
| 84295 | <1% | 31 | $1.47 | |
| 84520 | <1% | 31 | $1.47 | |
| 84132 | <1% | 98 | $1.47 | |
| 82435 | <1% | 31 | $1.47 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 25 | $0.00 |
| 87076 | 0% | 14 | $0.00 | |
| 84100 | 0% | 15 | $0.00 | |
| 82952 | 0% | 205 | $0.00 | |
| G0379 | Direct admission of patient for hospital observation care | 0% | 18 | $0.00 |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 0% | 12 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 25 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 14 | $0.00 |
| 82077 | 0% | 12 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 15 | $0.00 |
| 88304 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOMAYER, CORY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Memorial Health Systems INC | Daytona Beach, FL | $17.67M |
| Memorial Health Systems INC | Daytona Beach, FL | $7.43M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.